Atomwise snags $45M Series A
March 8, 2018- Share:
Drug Delivery | San Francisco, CA | Series A
Founded in 2012, Atomwise leverages AI to discover new medicines and agricultural compounds. The company, which has reportedly raised about $50 million to date, has been valued at $150 million with the fresh funds.
Select Investors
B Capital Group (lead),
Data Collective (lead),
Monsanto Growth Ventures (lead),
Baidu Capital,
Dolby Family Ventures
- Share:
-
-
-
-